期刊
MARINE DRUGS
卷 19, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/md19050241
关键词
cyanobacteria; clinical trials; antioxidant; antiviral; COVID-19; dietary supplements; biotechnological applications; total synthesis
资金
- Swedish Research links grant [VR 2016-05885]
- Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Sweden
Cyanobacteria produce bioactive compounds that have shown promising pharmacological activities in clinical trials, making them potential candidates for COVID-19 treatment. Large-scale synthesis of these compounds is essential to overcome issues with chemical isolation and further investigate their biological activities.
Cyanobacteria are photosynthetic prokaryotic organisms which represent a significant source of novel, bioactive, secondary metabolites, and they are also considered an abundant source of bioactive compounds/drugs, such as dolastatin, cryptophycin 1, curacin toyocamycin, phytoalexin, cyanovirin-N and phycocyanin. Some of these compounds have displayed promising results in successful Phase I, II, III and IV clinical trials. Additionally, the cyanobacterial compounds applied to medical research have demonstrated an exciting future with great potential to be developed into new medicines. Most of these compounds have exhibited strong pharmacological activities, including neurotoxicity, cytotoxicity and antiviral activity against HCMV, HSV-1, HHV-6 and HIV-1, so these metabolites could be promising candidates for COVID-19 treatment. Therefore, the effective large-scale production of natural marine products through synthesis is important for resolving the existing issues associated with chemical isolation, including small yields, and may be necessary to better investigate their biological activities. Herein, we highlight the total synthesized and stereochemical determinations of the cyanobacterial bioactive compounds. Furthermore, this review primarily focuses on the biotechnological applications of cyanobacteria, including applications as cosmetics, food supplements, and the nanobiotechnological applications of cyanobacterial bioactive compounds in potential medicinal applications for various human diseases are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据